Powered by
Helius Medical Technologies Announces Extension of Collaborative Research and Development Agreement (CRADA) with US Army
Sep 14, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

Corporate Wire Date: 13 September 2017 19:32 EDT

ORIGINAL ANNOUNCEMENT [Text]

NEWTOWN, Pa., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (OTCQB:HSDT) ("Helius" or the "Company") announced today that, through its wholly owned subsidiary NeuroHabilitation Corporation ("NHC"), it has executed an extension to its Cooperative Research and Development Agreement ("CRADA") with the US Army Medical Research and Materiel Comma

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox